StockData
Cencora, Inc. logo

Cencora, Inc.

CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 15/3019% above fair value
$339.09−2.16 (-0.63%)

Close on Nov 20, 2026Market cap $64.71BP/E 25.2Yield 0.65%

Cencora Peer Benchmark: McKesson Corporation (MCK) by Quarter

Peer Benchmark: McKesson Corporation (MCK) — Consolidated Revenue ($M) ($M)

Periods

Cencora Peer Benchmark: McKesson Corporation (MCK): $105,380M in Q3 FY26, up 7.7% from a year earlier.

Latest, Q3 FY26
105,380
Period ended Jun 30, 2026 (CQ2 2026)
Change on a year earlier
+7.7%
97,827 in Q3 FY25
History
67 quarters
Since Q3 FY08
Sources
1
SEC EDGAR XBRL CompanyFacts (MCK)

Where the Q3 FY26 figure comes from

“MCK us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax = $105,380,000,000 (2026-04-01 to 2026-06-30)”

Source: SEC EDGAR XBRL CompanyFacts (MCK) ↗

SEC XBRL quarterly and annual financial benchmark for Big-3 pharmaceutical distribution peer McKesson Corporation (CIK 0000927653, aligned to Cencora's fiscal calendar).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPeer Benchmark: McKesson Corporation (MCK) — Consolidated Revenue ($M) ($M)Year on yearSource
Q3 FY26CQ2 2026Jun 30, 2026105,380+7.7%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q1 FY26CQ4 2025Dec 31, 2025106,158+11.4%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q4 FY25CQ3 2025Sep 30, 2025103,150+10.1%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q3 FY25CQ2 2025Jun 30, 202597,827+23.4%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q1 FY25CQ4 2024Dec 31, 202495,294+17.8%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q4 FY24CQ3 2024Sep 30, 202493,651+21.3%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q3 FY24CQ2 2024Jun 30, 202479,283+6.4%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q1 FY24CQ4 2023Dec 31, 202380,898+14.8%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q4 FY23CQ3 2023Sep 30, 202377,215+10.1%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q3 FY23CQ2 2023Jun 30, 202374,483+10.9%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q1 FY23CQ4 2022Dec 31, 202270,490+2.7%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q4 FY22CQ3 2022Sep 30, 202270,157+5.4%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q3 FY22CQ2 2022Jun 30, 202267,154+7.1%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q1 FY22CQ4 2021Dec 31, 202168,614+9.6%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q4 FY21CQ3 2021Sep 30, 202166,576+9.5%SEC EDGAR XBRL CompanyFacts (MCK) ↗
Q3 FY21CQ2 2021Jun 30, 202162,674+12.6%SEC EDGAR XBRL CompanyFacts (MCK) ↗

Breakdown

What makes up peer Benchmark: McKesson Corporation (MCK)

Cite this data

StockData. (2026). Cencora Peer Benchmark: McKesson Corporation (MCK) ($M), quarterly Q3 FY08–Q3 FY26 [Data set]. Compiled from Cencora SEC filings and investor materials. https://stockdatahq.com/stocks/cor/kpis/peer-mck-rev

See every metric in the Cencora KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?